Search Results - "Stote, Robert M"

Refine Results
  1. 1

    Pharmacokinetics and pharmacodynamics of intranasal insulin administered to healthy subjects in escalating doses by Leary, Andrew C, Stote, Robert M, Breedt, H J, O'Brien, Jackie, Buckley, Brendan

    Published in Diabetes technology & therapeutics (01-02-2005)
    “…This exploratory study examined the pharmacokinetics and pharmacodynamics of a Bentley Pharmaceuticals, Inc. (North Hampton, NH) proprietary insulin…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Pharmacokinetics and pharmacodynamics of intranasal insulin administered to patients with type 1 diabetes: a preliminary study by Leary, Andrew C, Stote, Robert M, Cussen, Kathleen, O'Brien, Jackie, Leary, William P, Buckley, Brendan

    Published in Diabetes technology & therapeutics (01-02-2006)
    “…The pharmacokinetics and pharmacodynamics of a Bentley Pharmaceuticals (Exeter, NH) proprietary insulin formulation designed for intranasal administration were…”
    Get more information
    Journal Article
  4. 4

    The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics by Allison, N L, Dubb, J W, Ziemniak, J A, Alexander, F, Stote, R M

    Published in Clinical pharmacology and therapeutics (01-03-1987)
    “…Fenoldopam, a dopaminergic agonist, was administered intravenously to 18 healthy male subjects in doses ranging from 0.025 to 1.0 microgram/kg/min for 2 hours…”
    Get more information
    Journal Article
  5. 5

    A new oral renal vasodilator, fenoldopam by Stote, R M, Dubb, J W, Familiar, R G, Erb, B B, Alexander, F

    Published in Clinical pharmacology and therapeutics (01-09-1983)
    “…Fenoldopam, a dopamine agonist, was evaluated in renal clearance studies during water diuresis after oral doses of 25, 50, and 100 mg. After the 100-mg dose…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Effect on the endocrine system of a new dopaminergic agent, ibopamine by Soreth, J T, Dubb, J W, Allison, N L, Alexander, F, Boden, G, Stote, R M

    Published in Clinical pharmacology and therapeutics (01-06-1987)
    “…Ibopamine, an oral dopaminergic and adrenergic agent, was given to 19 healthy men to investigate the effect of this dopamine analogue on carbohydrate…”
    Get more information
    Journal Article
  8. 8

    Selectivity of metoclopramide for endocrine versus renal effects of dopamine in normal humans by Blumberg, A L, Dubb, J W, Allison, N L, Aldins, Z, Ramey, K, Stote, R M

    Published in Journal of cardiovascular pharmacology (01-02-1988)
    “…The purpose of the present study was to evaluate the effect on renal function of dopamine (low dose, 2 micrograms/kg/min) inhibition by a low-dose infusion of…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Pharmacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin) administered to healthy male volunteers: infuence of the nasal cycle by Leary, Andrew C, Dowling, Muiris, Cussen, Kathleen, O'Brien, Jackie, Stote, Robert M

    Published in Journal of diabetes science and technology (01-11-2008)
    “…The pharmacokinetics and pharmacodynamics of a Bentley Pharmaceuticals proprietary intranasal (IN) insulin formulation (Nasulin) were studied in healthy…”
    Get full text
    Journal Article
  11. 11

    Temelastine, a new H1-receptor antagonist by Alexander, F, Stote, R M, Allison, N, Familiar, R G, Tatoian, D, Dubb, J W

    “…Temelastine is a selective, competitive histamine H1-receptor antagonist which does not penetrate the central nervous system. The effect of varying doses of…”
    Get more information
    Journal Article
  12. 12

    Ticrynafen in anephric patients: effects on uric acid and pharmacokinetics by Murray, T G, Brown, S, Dubb, J W, Hwang, B Y, Stote, R M

    Published in Clinical pharmacology and therapeutics (01-05-1980)
    “…Ticrynafen was given to 6 anephric patients undergoing maintenance hemodialysis. Ticrynafen was given daily for the 3 days between hemodialyses. Ticrynafen had…”
    Get more information
    Journal Article
  13. 13

    Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients by Jorkasky, D K, Audet, P, Shusterman, N, Ilson, B, Dafoe, D, Hedrich, D, Stote, R M

    Published in American journal of kidney diseases (01-06-1992)
    “…Cyclosporine causes renal vasoconstriction and reduced renal blood flow that may contribute to chronic nephrotoxicity. This effect has not been consistently…”
    Get more information
    Journal Article
  14. 14

    Bioavailability of cimetidine in man by Walkenstein, S S, Dubb, J W, Randolph, W C, Westlake, W J, Stote, R M, Intoccia, A P

    Published in Gastroenterology (New York, N.Y. 1943) (01-02-1978)
    “…The bioavailability of parenteral cimetidine was tested in 12 volunteers in a balanced three-way crossover study. Blood levels and urinary excretion were…”
    Get more information
    Journal Article
  15. 15

    Effect of cimetidine on renal function in normal man by Dubb, J W, Stote, R M, Familiar, R G, Lee, K, Alexander, F

    Published in Clinical pharmacology and therapeutics (01-07-1978)
    “…To evaluate the effect of acute histamine H2-receptor blockade on renal function, renal function studies were performed in a control state and after…”
    Get more information
    Journal Article
  16. 16

    A retrospective analysis of fenoldopam renal excretion in 65 subjects: evidence for possible intrarenal formation of fenoldopam from its metabolites by ZIEMNIAK, J. A, BOPPANA, V. K, CYRONAK, M. J, STOTE, R. M

    Published in Pharmaceutical research (01-08-1989)
    “…Clinical studies have suggested that the dopamine DA1 agonist, fenoldopam, may exhibit nonlinear renal excretion in humans. A retrospective population…”
    Get full text
    Journal Article
  17. 17

    Intraoperative versus routine hemodialysis in end-stage renal disease patients undergoing open-heart surgery by Ilson, B E, Bland, P S, Jorkasky, D K, Shusterman, N, Allison, N L, Dubb, J W, Parr, G V, Goebel, T K, Stote, R M

    Published in Nephron (2015) (1992)
    “…Of 13 chronic hemodialysis end-stage renal disease (ESRD) patients undergoing open-heart surgery, 7 received intraoperative hemodialysis (IHD) during…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Oxypurinol nephrolithiasis in regional enteritis secondary to allopurinol therapy by Stote, R M, Smith, L H, Dubb, J W, Moyer, T P, Alexander, F, Roth, J L

    Published in Annals of internal medicine (01-03-1980)
    “…A patient with regional enteritis and recurrent uric acid nephrolithiasis was treated with allopurinol. While on 600 mg of allopurinol daily, she began to pass…”
    Get more information
    Journal Article
  20. 20

    Ticrynafen, a uricosuric antihypertensive diuretic by Stote, R M, Dubb, J W, Familiar, R G, Alexander, F

    Published in Clinical pharmacology and therapeutics (01-04-1978)
    “…Ticrynafen, a diuretic-uricosuric also effective as an antihypertensive, was compared in single doses with several other diuretics. Over an 8-hr period, a 250-…”
    Get more information
    Journal Article